---
title: "Nicotinyl Alcohol - Hyperlipidemia"
sidebar: mydoc_sidebar
permalink: db04145-mesh-d006949-1.html
toc: false 
---


Path ID: `DB04145_MESH_D006949_1`
{% include image.html url="images/db04145-mesh-d006949-1.png" file="db04145-mesh-d006949-1.png" alt="db04145-mesh-d006949-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D009540">MESH:D009540 </a> | Nicotinyl alcohol | Drug |
| <a href="https://identifiers.org/CHEBI:15940">CHEBI:15940 </a> | Nicotinic acid | ChemicalSubstance |
| <a href="https://identifiers.org/UniProt:P49019">UniProt:P49019 </a> | Hydroxycarboxylic acid receptor 3 | Protein |
| <a href="https://identifiers.org/UniProt:Q8TDS4">UniProt:Q8TDS4 </a> | Hydroxycarboxylic acid receptor 2 | Protein |
| <a href="https://identifiers.org/UniProt:Q96PD7">UniProt:Q96PD7 </a> | Diacylglycerol O-acyltransferase 2 | Protein |
| <a href="https://identifiers.org/MESH:D005227">MESH:D005227 </a> | Fatty Acids | ChemicalSubstance |
| <a href="https://identifiers.org/UniProt:P02656">UniProt:P02656 </a> | Apolipoprotein C-III | Protein |
| <a href="https://identifiers.org/MESH:D015243">MESH:D015243 </a> | Cholesterol, VLDL | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D014280">MESH:D014280 </a> | Triglycerides | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D006949">MESH:D006949 </a> | Hyperlipidemia | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Nicotinyl Alcohol | INCREASES ABUNDANCE OF | Nicotinic Acid |
| Nicotinic Acid | INCREASES ACTIVITY OF | Hydroxycarboxylic Acid Receptor 3 |
| Nicotinic Acid | INCREASES ACTIVITY OF | Hydroxycarboxylic Acid Receptor 2 |
| Nicotinic Acid | DECREASES ACTIVITY OF | Diacylglycerol O-Acyltransferase 2 |
| Hydroxycarboxylic Acid Receptor 3 | DECREASES ABUNDANCE OF | Fatty Acids |
| Hydroxycarboxylic Acid Receptor 2 | DECREASES ABUNDANCE OF | Fatty Acids |
| Diacylglycerol O-Acyltransferase 2 | INCREASES ABUNDANCE OF | Triglycerides |
| Fatty Acids | INCREASES ACTIVITY OF | Apolipoprotein C-Iii |
| Apolipoprotein C-Iii | POSITIVELY CORRELATED WITH | Cholesterol, Vldl |
| Cholesterol, Vldl | POSITIVELY CORRELATED WITH | Hyperlipidemia |
| Triglycerides | POSITIVELY CORRELATED WITH | Hyperlipidemia |
|---------|-----------|---------|

Comment: Nicotinyl alcohol has been shown to be metabolized rapidly to nicotinic acid (niacin) [https://pubmed.ncbi.nlm.nih.gov/4883785/](https://pubmed.ncbi.nlm.nih.gov/4883785/)

Reference: 
  - [https://go.drugbank.com/drugs/DB04145](https://go.drugbank.com/drugs/DB04145)
  - [https://en.wikipedia.org/wiki/Nicotinyl_alcohol](https://en.wikipedia.org/wiki/Nicotinyl_alcohol)
  - [https://en.wikipedia.org/wiki/Hyperlipidemia](https://en.wikipedia.org/wiki/Hyperlipidemia)
  - [https://go.drugbank.com/drugs/DB00627](https://go.drugbank.com/drugs/DB00627)
  - [https://en.wikipedia.org/wiki/Niacin#As_lipid-modifying_medication](https://en.wikipedia.org/wiki/Niacin#As_lipid-modifying_medication)
